Annette Carter

Annette Carter serves as a Contracting Officer responsible for managing complex acquisitions in scientific and pharmaceutical research domains. She plays a critical role in ensuring the agency’s mission-critical procurement needs are met through compliant, transparent, and efficient contracting practices. Her portfolio primarily encompasses research and development services in the physical, engineering, and life sciences, alongside pharmaceutical preparation manufacturing activities. She oversees the full acquisition lifecycle—from market research and solicitation development to contract award and administration—ensuring alignment with federal regulations and strategic technical objectives. While specific contractor relationships are not publicly identified, Annette consistently engages with a diverse pool of vendors possessing advanced technical capabilities in laboratory research, analytical instrumentation, and GMP-compliant pharmaceutical formulation. Her procurement approach emphasizes performance-based contracting and risk mitigation, fostering long-term partnerships with firms that demonstrate proven expertise in regulated scientific environments. She prioritizes clear statement of work development and rigorous source selection criteria to ensure contract outcomes meet rigorous technical and compliance standards. Annette’s contracting patterns reflect a strong preference for full and open competition, with 100% of her awards issued without set-aside designations. This indicates a focus on technical merit and capability over socioeconomic categorization, though she remains compliant with all applicable small business statutes. Her approach suggests a strategic emphasis on securing the highest-quality scientific and manufacturing services, regardless of vendor size, while maintaining full adherence to FAR and agency-specific procurement policies. Her primary NAICS focus areas—541712 for research and development in the physical, engineering, and life sciences, and 325412 for pharmaceutical preparation manufacturing—reveal deep specialization in early-stage R&D, clinical trial support, and active pharmaceutical ingredient processing. She routinely procures services including analytical validation, process scale-up, regulatory documentation, and laboratory automation systems, demonstrating subject-matter expertise in highly regulated scientific domains.